Opportunistic infections update.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy; D009181:Mycoses / Q000188:drug therapy; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control; D012514:Sarcoma, Kaposi / Q000188:drug therapy
D000890:Anti-Infective Agents; D000935:Antifungal Agents; D000970:Antineoplastic Agents; D000995:Antitubercular Agents; D000998:Antiviral Agents